Cargando…
A multicentre clinical study on the injection of ceftriaxone/sulbactam compared with cefoperazone/sulbactam in the treatment of respiratory and urinary tract infections
OBJECTIVE: This clinical study was designed to evaluate the efficacy and safety of this therapy in the treatment of respiratory and urinary infections caused by ceftriaxone-resistant bacteria in comparison with the effect of cefoperazone/sulbactam on cefoperazone-resistant bacteria. METHODS: A total...
Autores principales: | Xin, Xiaojuan, Jian, Li, Xia, Xiaoying, Jia, Bei, Huang, Wenxiang, Li, Chongzhi, Wang, Changzheng, Zhou, Lixin, Sun, Xiuzhen, Tang, Xinghuo, Huang, Yijiang, Zhu, Yunkui, Zhang, Weili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029302/ https://www.ncbi.nlm.nih.gov/pubmed/24321187 http://dx.doi.org/10.1186/1476-0711-12-38 |
Ejemplares similares
-
Hypersensitivity vasculitis induced by cefoperazone/sulbactam
por: Islek, Ismail, et al.
Publicado: (2003) -
Cefoperazone-Sulbactam Associated Refractory Seizures
por: Chovatiya, Harshad, et al.
Publicado: (2021) -
Cefoperazone/sulbactam-induced hemolytic anemia
por: Sun, XM, et al.
Publicado: (2023) -
In Vitro Antimicrobial Activity of Various Cefoperazone/Sulbactam Products
por: Sheu, Ming-Jen, et al.
Publicado: (2020) -
Hemolytic Anemia and Reactive Thrombocytosis Associated With Cefoperazone/Sulbactam
por: Zhou, Ling, et al.
Publicado: (2019)